Drug
Gatifloxacin clinical trials
Also written Zymar.
- studies test it
- 13
- open now
- 0
- in phase 3
- 2
- first study started
- 2003
How studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 2
- Phase 4
- 5
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 8
Allergan (4) · Stanford University (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Oxford University Clinical Research Unit, Vietnam (1) · Walter Reed Army Medical Center (1) · Santen Inc. (1) · Cornea Consultants Of Nashville (1) · Queen's University (1)
Often tested with
Tested in the same studies.
Moxifloxacin (6) · Levofloxacin (2) · Linezolid (1) · Ceftriaxone (1) · Besifloxacin (1)
Studies
Open first, then newest update. How each study uses Gatifloxacin is read from its arms, and is right about nine times in ten.
Testing it · 13
- A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedPhase 3AllerganNCT00518089Written as Gatifloxacin 0.5% eye drops
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary TuberculosisCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00396084Written as Gatifloxacin
- Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract SurgeryWithdrawnNot applicableQueen's UniversityNCT00335231Written as gatifloxacin ophthalmic (ZYMAR)
- Topical Antibiotics and Intravitreous InjectionsCompletedPhase 4Stanford UniversityNCT00410891Written as gatifloxacin
- Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric FeverCompletedPhase 4Oxford University Clinical Research Unit, VietnamNCT01421693Written as Gatifloxacin
- A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.TerminatedPhase 2Cornea Consultants Of NashvilleNCT01928693Written as Zymaxid 0.5% Ophthalmic Solution
- One Hour Preoperative GatifloxacinCompletedPhase 4Stanford UniversityNCT00350363Written as Zymar
- Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)CompletedNot applicableWalter Reed Army Medical CenterNCT00414011Written as Gatifloxacin
- Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour ApplicationWithdrawnNot applicableStanford UniversityNCT00466570Written as gatifloxacin, moxifloxacin
- A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant OrganismsCompletedPhase 4AllerganNCT00874887Written as gatifloxacin ophthalmic solution 0.3%
- A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedPhase 3AllerganNCT00509873Written as Gatifloxacin 0.5% eye drops
- Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active ComparatorsCompletedPhase 4Santen Inc.NCT00703313Written as 0.3% gatifloxacin ophthalmic solution
- Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal UlcersCompletedPhase 2AllerganNCT00651586Written as Gatifloxacin 0.3% ophthalmic solution
Given in every arm · 1 — Gatifloxacin is usual care beside what is tested
As the comparator · 6 — what is tested is compared with Gatifloxacin
- Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.TerminatedPhase 3Laboratorios Sophia S.A de C.V.NCT03696342Written as Zymar
- Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)CompletedPhase 2Laboratorios Sophia S.A de C.V.NCT02980523Written as Zymar®
- Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/InflammationCompletedPhase 3Federal University of São PauloNCT01218737Written as isolated 0.3% gatifloxacin and 1.0% prednisolone acetate
- Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial ConjunctivitisTerminatedPhase 3Bausch & Lomb IncorporatedNCT01330355Written as Gatifloxacin
- Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of SubjectsCompletedPhase 1Bausch & Lomb IncorporatedNCT00824070Written as gatifloxacin
- Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical InstillationCompletedPhase 1Bausch & Lomb IncorporatedNCT00905762Written as Gatifloxacin
Codes
What other systems call Gatifloxacin · ClinicalTrials.gg INT006798
- MeSH (NLM) D000077734GatifloxacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) L4618BD7KJGATIFLOXACINConfirmed FDA, NLM
- RxNorm 228476One source FDA
- NCI Thesaurus C29070GatifloxacinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077734 | Gatifloxacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | L4618BD7KJ | GATIFLOXACIN | Confirmed FDA, NLM |
| RxNorm | 228476 | — | One source FDA |
| NCI Thesaurus | C29070 | Gatifloxacin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.